Through the week of Jan. 29, 19 states are reported “high” respiratory virus activity: Kansas, Nebraska, South Dakota, Minnesota, Iowa, Arkansas, Illinois, Indiana, Kentucky, Mississippi, Georgia, North Carolina, Michigan, Pennsylvania, Ohio, New York, Massachusetts, Connecticut and Delaware.
Seven states experienced “very high” levels: Texas, Oklahoma, Wisconsin, Florida, South Carolina, New Jersey and New Hampshire.
Here are four more updates:
- Influenza test positivity has increased to 29.4%, while COVID-19 test positivity remained stable at 5.4% and RSV positivity decreased to 7.6%.
- Wastewater surveillance showed very high levels of influenza A viral activity, high levels of COVID-19 and moderate levels of RSV activity.
- The CDC forecast that influenza-related ED visits will remain high over the coming weeks and are expected to increase in most states. COVID-19 and RSV activity levels are expected to dip slightly.
- Vaccination rates continue to be of concern, with COVID-19 and influenza vaccination coverage lower than desired. RSV vaccines are seeing very low uptake among children and adults, according to the CDC.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
